As cancer survivors live longer, technologies improve, and reirradiation (reRT) becomes more common, standardised methods for the assessment and reporting of cumulative radiation doses are needed to allow treatment optimisation and integration with other medical specialties managing these complex patients. This consensus statement, developed by an international collaboration of radiation oncologists, physicists, and other experts in the Reirradiation Collaborative Group,…
[Policy Review] Reirradiation Collaborative Group (ReCOG) consensus on standards for dose evaluation and reporting in patients with multiple courses of radiation therapy: an AAPM/ACRO/ASTRO/CARO/COMP/CADRA/CPQR/ESTRO/NRG-endorsed consensus statement
The Lancet Oncology | | Kelly C Paradis, Ane L Appelt, Soren M Bentzen, Nick Chng, Elizabeth L Covington, Laura A Dawson, Dorota Gabryś, Dwight E Heron, Lone Hoffmann, Andrew Jackson, Lawrence B Marks, Charles Mayo, Kilian E Salerno, Charles B Simone, Ying Xiao, Ellen Yorke, Philip Poortmans, Jeffrey C Buchsbaum
Topics: blood-cancer, sarcoma, radiation